Current research on genistein is promising but not conclusive. In-vitro and in-vivo studies have demonstrated significant anticancer effects, but human trials are limited and often yield mixed results. Ongoing research aims to clarify the optimal doses, safety, and efficacy of genistein in cancer prevention and treatment.
